available with approved dosing regimens for children and adolescents.
The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...
SAN FRANCISCO -- Immunex Corp. will tell doctors its popular rheumatoid arthritis drug Enbrel can treat other joint and spinal disorders, part of a strategy to expand the market for Enbrel and keep it ...
SAN FRANCISCO (MarketWatch) - Amgen Inc. was ordered by regulators to pull a television ad that overstated the effectiveness of its Enbrel psoriasis treatment. In a letter to Amgen AMGN Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results